A day after Canadian officials suspended the use of a hyperactivity drug amid reports of deaths associated with its use, Senator Charles E. Grassley of Iowa contended that United States health officials had asked the Canadian regulators not to do so.
Senator Grassley, a Republican, said on Thursday that the Food and Drug Administration had made the request of Canadian health officials because the F.D.A. could not handle another "drug safety crisis." Mr. Grassley said he was basing his contentions on reports from whistle-blowers within the agency.
No comments:
Post a Comment